| Literature DB >> 29518075 |
Lester Darryl Geneviève1, Nicolas Ray2, François Chappuis3, Gabriel Alcoba3,4, Maria Rosa Mondardini5, Isabelle Bolon1, Rafael Ruiz de Castañeda1.
Abstract
Entities:
Mesh:
Substances:
Year: 2018 PMID: 29518075 PMCID: PMC5843214 DOI: 10.1371/journal.pntd.0006162
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
General characteristics of citizen-generated observations and scientist-generated observations datasets.
| Characteristics | Datasets | |
|---|---|---|
| Citizen-generated observations | Scientist-generated observations | |
| Time frame of observations | 1967–2017 | 1700–2016 |
| Number of observations | 9,113 | 70,697 |
| Number of countries with observations | 96 | 137 |
| Number of observed species from WHO MIVS list (219 species) | 122 (55.7%) | 177 (80.8%) |
a Among the 70,697 scientist-generated observations, 20,049 did not have their date of observation.
Abbreviations: MIVS, medically important venomous snakes; WHO, World Health Organization.
Fig 1Geographical distribution of MIVS citizen-generated (n = 9,113) and scientist-generated (n = 70,697) observations on global map illustrating snakebite mortality for GBD regions of the world.
The time frames for citizen-generated and scientist-generated observations are from 1967 to 2017 and 1700 to 2016 respectively. The color scale illustrates the mortality for these regions based on figures provided by Kasturiratne et al. (2008) [12]. Source: Made with Natural Earth. Free vector and raster map data available from www.naturalearthdata.com. The map (countries cultural theme version 3.1.0) is adapted and projected in the World Robinson coordinate reference system on QGIS 2.18.2. Abbreviations: GBD, global burden of disease; MIVS, medically important venomous snakes.
Geographical distribution of citizen-generated and scientist-generated snake species observations.
| GBD regions | Citizen-generated observations | Scientist-generated observations | Species coincidence | ||
|---|---|---|---|---|---|
| No. of observations | No. of MIVS species | No. of observations | No. of MIVS species | ||
| Andean Latin America | 44 (0.5%) | 9 | 606 (0.9%) | 18 | 50 |
| Australasia | 85 (0.9%) | 9 | 17,920 (25.3%) | 15 | 60 |
| Caribbean | 8 (0.1%) | 2 | 200 (0.3%) | 13 | 15 |
| Central Asia | 25 (0.3%) | 6 | 50 (0.1%) | 7 | 44 |
| Central Europe | 24 (0.3%) | 3 | 32 (0.0%) | 3 | 100 |
| Central Latin America | 693 (7.6%) | 32 | 9,434 (13.3%) | 47 | 65 |
| Central sub-Saharan Africa | 10 (0.1%) | 7 | 422 (0.6%) | 18 | 39 |
| East Asia | 26 (0.3%) | 5 | 298 (0.4%) | 16 | 31 |
| Eastern Europe | 8 (0.1%) | 3 | 8 (0.0%) | 2 | 67 |
| Eastern sub-Saharan Africa | 44 (0.5%) | 14 | 1,459 (21%) | 28 | 50 |
| High-income Pacific Asia | 78 (0.9%) | 6 | 221 (0.3%) | 14 | 33 |
| High-income North America | 7,238 (79.4%) | 14 | 24,552 (34.7%) | 22 | 64 |
| North Africa and Middle East | 51 (0.6%) | 14 | 542 (0.8%) | 20 | 30 |
| Oceania | 0 (0.0%) | 0 | 284 (0.4%) | 6 | N/A |
| South Asia | 426 (4.7%) | 9 | 115 (0.2%) | 19 | 33 |
| Southeast Asia | 31 (0.3%) | 13 | 1,008 (1.4%) | 41 | 26 |
| Southern Latin America | 0 (0.0%) | 0 | 554 (0.8%) | 13 | N/A |
| Southern sub-Saharan Africa | 76 (0.8%) | 11 | 2,551 (3.6%) | 18 | 61 |
| Tropical Latin America | 8 (0.1%) | 5 | 1,529 (2.2%) | 19 | 42 |
| Western Europe | 219 (2.4%) | 12 | 6,905 (9.8%) | 14 | 73 |
| Western sub-Saharan Africa | 19 (0.2%) | 10 | 2,007 (2.8%) | 24 | 36 |
a Percentage of snake species matched between citizen-generated and scientist-generated sources of observational data
Abbreviations: GBD, global burden of disease; MIVS, medically important venomous snakes; N/A, not applicable.
Most commonly observed MIVS species in citizen-generated and scientist-generated data sources per GBD region.
| GBD regions | Citizen-generated observations | Scientist-generated observations |
|---|---|---|
| Andean Latin America | ||
| Australasia | ||
| Caribbean | ||
| Central Asia | ||
| Central Europe | ||
| Central Latin America | ||
| Central sub-Saharan Africa | ||
| East Asia | ||
| Eastern Europe | ||
| East sub-Saharan Africa | ||
| High-income Asia Pacific | ||
| High-income North America | ||
| North Africa and Middle East | ||
| Oceania | ||
| South Asia | ||
| Southeast Asia | ||
| Southern Latin America | ||
| Southern sub-Saharan Africa | ||
| Tropical Latin America | ||
| Western Europe | ||
| Western sub-Saharan Africa |
Abbreviations: GBD, Global burden of disease; MIVS, medically important venomous snakes.